Ravi Srinivasan

Ravi is a partner based in our London office. Ravi is known for his practical and commercial approach to patent work. He handles cases in both organic and inorganic chemistry, with particular expertise in the pharmaceutical field where he advises start-up companies as well as medium-sized and large pharmaceutical companies.

In the pharmaceutical field, Ravi has acted in many high-profile conflicts, on drugs including doxorubicin, epirubicin, docetaxel, aclidinium, ebastine, plerixfor, betrixaben, aztreonam, heparin, risperidone, actikerall, upadacitinib, vilanterol, umeclidinium bromide, dolutegravir and sofosbuvir. He has an impressive track record in defending patent estates protecting innovative pharmaceutical products. He is equally at home advising on freedom to operate and due diligence matters and drafting, filing and prosecuting patent applications at the European Patent Office (EPO) and elsewhere. Many of Ravi’s clients have broad filing programmes, and Ravi routinely takes responsibility for filing pharmaceutical applications in over 40 countries.

Outside the pharmaceutical field, Ravi assists clients in the cleantech sector. He works closely with businesses seeking to improve fuel and lubricant technologies and companies developing renewable energy sources. Much of this work involves filing and defending oppositions at the European Patent Office, an area where Ravi has extensive experience.

In addition to his experience at the European Patent Office, Ravi is a qualified litigator and holds the Higher Courts Litigation Certificate. This enables him to conduct IP litigation in the Intellectual Property Enterprise Court and the High Court and on appeal to the Court of Appeal and the Supreme Court.

Ravi is an overseas citizen of India and a frequent visitor to the country. He has specialist expertise in prosecuting Indian patent applications and experience of speaking at an opposition hearing at the Indian Patent Office.

Ranked in the top tier of Chambers and Partners, clients comment that “His insights and attention to detail are second to none – we have no hesitation in recommending him to others.” Managing Intellectual Property has identified Ravi as one of J A Kemp’s “impressive array of talent” who is considered by clients to be “one of the best attorneys out there”. IAM Patent 1000 identifies Ravi as a “recommended individual” for his expertise in pharmaceuticals and comments that he is “incredibly bright”, “has a good feel for issues of strategy” and is “very conscientious and proactive when it comes to suggesting ways forward when patents run into difficulties”. Ravi is recommended by Who’s Who: Patents. The Legal 500 comments that “Ravi’s knowledge, experience and interest in UK litigation sets him apart”.

Ravi joined J A Kemp in 1994 and became a partner in 2000.